Cargando…
One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis
BACKGROUND: This study compared 1-year risk of psychiatric hospitalization and treatment costs in commercially insured patients with bipolar disorder, treated with aripiprazole, ziprasidone, olanzapine, quetiapine or risperidone. METHODS: This was a retrospective propensity score-matched cohort stud...
Autores principales: | Kim, Edward, You, Min, Pikalov, Andrei, Van-Tran, Quynh, Jing, Yonghua |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036592/ https://www.ncbi.nlm.nih.gov/pubmed/21214937 http://dx.doi.org/10.1186/1471-244X-11-6 |
Ejemplares similares
-
Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
por: O’Day, Ken, et al.
Publicado: (2013) -
The Use of Atypical Antipsychotics in Treating a Pediatric Psychiatric Patient
por: Jogie, Joshua A, et al.
Publicado: (2022) -
The use of atypical antipsychotics in Bipolar Spectrum disorders
por: Grünze, H., et al.
Publicado: (2003) -
Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy
por: Nadkarni, Anagha, et al.
Publicado: (2013) -
Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients
por: Torrent, Carla, et al.
Publicado: (2010)